SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
28-Dec-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 28-Dec-23 | Purchase | 857 | $13.35 | $11,441.20 | < 1% 533.15K to 534.01K | |
28-Dec-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 26-Dec-23 | Purchase | 48,693 | $13.15 | $640,313.00 | 10% 484.46K to 533.15K | |
11-Dec-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 07-Dec-23 | Purchase | 101,050 | $12.85 | $1,298,470.00 | 5% 2.12M to 2.22M | |
20-Nov-23 10:00 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 17-Nov-23 | Purchase | 300 | $12.50 | $3,750.00 | < 1% 2.12M to 2.12M | |
16-Nov-23 5:09 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 14-Nov-23 | Purchase | 50,170 | $12.50 | $627,125.00 | 2% 2.07M to 2.12M | |
14-Nov-23 10:00 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 13-Nov-23 | Purchase | 15,570 | $12.39 | $192,875.00 | < 1% 2.05M to 2.07M | |
14-Nov-23 10:00 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 10-Nov-23 | Purchase | 38,062 | $12.32 | $469,008.00 | 2% 2.01M to 2.05M | |
13-Nov-23 10:00 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 09-Nov-23 | Purchase | 9,975 | $12.19 | $121,618.00 | < 1% 2.0M to 2.01M | |
13-Nov-23 10:00 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 08-Nov-23 | Purchase | 13,823 | $12.13 | $167,701.00 | < 1% 1.99M to 2.0M | |
14-Aug-23 4:06 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 11-Aug-23 | Purchase | 2,000 | $12.43 | $24,865.20 | 2% 131.1K to 133.1K | |
14-Aug-23 4:06 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 10-Aug-23 | Purchase | 2,000 | $12.52 | $25,039.20 | 2% 131.1K to 133.1K | |
09-Aug-23 4:06 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 08-Aug-23 | Purchase | 87,057 | $12.00 | $1,044,330.00 | 5% 1.9M to 1.99M | |
09-Aug-23 4:06 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 07-Aug-23 | Purchase | 134,493 | $12.00 | $1,614,410.00 | 8% 1.77M to 1.9M | |
22-Mar-23 4:06 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 21-Mar-23 | Purchase | 160,590 | $11.52 | $1,850,000.00 | 10% 1.61M to 1.77M | |
01-Feb-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 31-Jan-23 | Purchase | 2,232 | $11.40 | $25,444.40 | < 1% 1.61M to 1.61M | |
01-Feb-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 30-Jan-23 | Purchase | 24,708 | $11.36 | $280,624.00 | 2% 1.58M to 1.61M | |
31-Jan-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 27-Jan-23 | Purchase | 21,875 | $11.40 | $249,298.00 | 1% 1.56M to 1.58M | |
17-Jan-23 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 12-Jan-23 | Purchase | 100,000 | $11.90 | $1,190,000.00 | 10% 1.02M to 1.12M | |
09-Jan-23 4:06 PM View: | Radeljevic Ana Director | Merrimack Pharmaceuticals, ... (MACK) | 06-Jan-23 | Purchase | 4,156 | $12.03 | $49,996.70 | 100% 0 to 4.16K | |
04-Jan-23 4:05 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 03-Jan-23 | Purchase | 30,632 | $11.33 | $347,159.00 | 2% 1.53M to 1.56M | |
04-Jan-23 4:06 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 03-Jan-23 | Purchase | 5,300 | $11.24 | $59,563.50 | < 1% 1.01M to 1.02M | |
03-Jan-23 4:16 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 30-Dec-22 | Purchase | 41,300 | $11.33 | $468,040.00 | 3% 1.49M to 1.53M | |
04-Jan-23 4:06 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 30-Dec-22 | Purchase | 1,300 | $11.24 | $14,615.00 | < 1% 1.01M to 1.01M | |
03-Jan-23 4:16 PM View: | Andersen Eric Director | Merrimack Pharmaceuticals, ... (MACK) | 29-Dec-22 | Purchase | 218,636 | $10.55 | $2,306,680.00 | 17% 1.27M to 1.49M | |
15-Jul-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 13-Jul-22 | Purchase | 3,095 | $5.89 | $18,226.80 | < 1% 751.01K to 754.11K | |
13-Jul-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 12-Jul-22 | Purchase | 2,816 | $5.86 | $16,515.60 | < 1% 748.2K to 751.01K | |
13-Jul-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 11-Jul-22 | Purchase | 700 | $5.97 | $4,181.59 | < 1% 747.5K to 748.2K | |
11-Jul-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 08-Jul-22 | Purchase | 1,378 | $5.99 | $8,249.12 | < 1% 746.12K to 747.5K | |
11-Jul-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 07-Jul-22 | Purchase | 1,100 | $5.99 | $6,586.03 | < 1% 745.02K to 746.12K | |
05-Jul-22 4:06 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 30-Jun-22 | Purchase | 1,550 | $5.76 | $8,921.49 | < 1% 743.47K to 745.02K | |
27-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 24-Jun-22 | Purchase | 1,000 | $5.99 | $5,990.00 | < 1% 742.47K to 743.47K | |
27-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 23-Jun-22 | Purchase | 500 | $6.00 | $3,000.00 | < 1% 741.97K to 742.47K | |
21-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 17-Jun-22 | Purchase | 900 | $5.97 | $5,372.28 | < 1% 1.75M to 1.75M | |
21-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 16-Jun-22 | Purchase | 520 | $5.45 | $2,832.96 | < 1% 1.75M to 1.75M | |
16-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 15-Jun-22 | Purchase | 2,900 | $5.37 | $15,561.10 | < 1% 1.75M to 1.75M | |
16-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 14-Jun-22 | Purchase | 20,938 | $5.17 | $108,319.00 | 1% 1.73M to 1.75M | |
14-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 13-Jun-22 | Purchase | 9,699 | $5.15 | $49,938.20 | < 1% 1.72M to 1.73M | |
14-Jun-22 4:05 PM View: | Levy Noah G. Director | Merrimack Pharmaceuticals, ... (MACK) | 10-Jun-22 | Purchase | 6,386 | $4.92 | $31,423.00 | < 1% 1.71M to 1.72M | |
13-Jun-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 09-Jun-22 | Purchase | 4,452 | $5.15 | $22,918.00 | 4% 126.65K to 131.1K | |
09-Jun-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 08-Jun-22 | Purchase | 349 | $5.14 | $1,795.12 | < 1% 126.3K to 126.65K | |
09-Jun-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 07-Jun-22 | Purchase | 300 | $5.05 | $1,515.00 | < 1% 126.0K to 126.3K | |
26-May-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 25-May-22 | Purchase | 132 | $5.13 | $677.79 | < 1% 125.87K to 126.0K | |
26-May-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 24-May-22 | Purchase | 2,323 | $5.09 | $11,816.90 | 2% 123.55K to 125.87K | |
23-May-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 19-May-22 | Purchase | 512 | $5.04 | $2,581.91 | < 1% 123.04K to 123.55K | |
19-May-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 18-May-22 | Purchase | 5,000 | $5.08 | $25,407.00 | 4% 118.04K to 123.04K | |
19-May-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 17-May-22 | Purchase | 225 | $5.10 | $1,146.51 | < 1% 117.81K to 118.04K | |
16-May-22 10:00 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 13-May-22 | Purchase | 3 | $4.90 | $14.70 | < 1% 117.81K to 117.81K | |
16-May-22 10:00 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 12-May-22 | Purchase | 2,471 | $5.04 | $12,456.10 | 2% 115.34K to 117.81K | |
25-Apr-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 21-Apr-22 | Purchase | 5,000 | $6.00 | $30,001.00 | 5% 110.34K to 115.34K | |
01-Apr-22 4:05 PM View: | Crocker Gary L See Remarks Director | Merrimack Pharmaceuticals, ... (MACK) | 31-Mar-22 | Purchase | 300 | $6.18 | $1,853.01 | < 1% 110.04K to 110.34K |